Investment
Features
FeesSafety
Academy
More
Pluang+

Pulnovo Medical raises $100M in oversubscribed round led by Medtronic to expand global growth and commercialization.

Company Fundamentals
19 Apr 2026
PRNewsWire
View Source
Bullish
pluang ai news

Pulnovo Medical secured $100 million in an oversubscribed financing round led by Medtronic and supported by existing and new investors, marking a key milestone for its global expansion. The funding will accelerate clinical development, regulatory approvals, and commercialization of its Pulmonary Artery Denervation (PADN) System, a breakthrough therapy for pulmonary hypertension and heart failure. Pulnovo has FDA Breakthrough Device designation and ongoing trials in the US, Europe, and Asia, aiming to improve patient outcomes worldwide. The company also announced a commercial agreement with Medtronic to leverage their global commercialization capabilities.

More News (MDT)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App